As of 2025-07-01, the Relative Valuation of Crinetics Pharmaceuticals Inc (CRNX) is (45.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.76 USD, the upside of Crinetics Pharmaceuticals Inc based on Relative Valuation is -256.6%.
The range of the Relative Valuation is (34.69) - (61.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 17.7x | 12.6x |
| Forward P/E multiples | 9.9x - 20.1x | 13.1x |
| Fair Price | (34.69) - (61.95) | (45.03) |
| Upside | -220.6% - -315.4% | -256.6% |
| Date | P/E |
| 2025-06-27 | -8.55 |
| 2025-06-26 | -8.56 |
| 2025-06-25 | -8.68 |
| 2025-06-24 | -8.83 |
| 2025-06-23 | -8.54 |
| 2025-06-20 | -8.61 |
| 2025-06-18 | -8.70 |
| 2025-06-17 | -8.80 |
| 2025-06-16 | -8.90 |
| 2025-06-13 | -9.07 |
| 2025-06-12 | -9.18 |
| 2025-06-11 | -9.23 |
| 2025-06-10 | -9.44 |
| 2025-06-09 | -9.21 |
| 2025-06-06 | -9.42 |
| 2025-06-05 | -9.22 |
| 2025-06-04 | -9.17 |
| 2025-06-03 | -9.16 |
| 2025-06-02 | -9.10 |
| 2025-05-30 | -8.71 |
| 2025-05-29 | -8.71 |
| 2025-05-28 | -8.54 |
| 2025-05-27 | -8.42 |
| 2025-05-23 | -8.49 |
| 2025-05-22 | -8.59 |
| 2025-05-21 | -8.55 |
| 2025-05-20 | -8.95 |
| 2025-05-19 | -8.83 |
| 2025-05-16 | -8.92 |
| 2025-05-15 | -8.91 |
| 2025-05-14 | -8.93 |
| 2025-05-13 | -8.83 |
| 2025-05-12 | -9.51 |
| 2025-05-09 | -8.76 |
| 2025-05-08 | -9.33 |
| 2025-05-07 | -8.96 |
| 2025-05-06 | -8.71 |
| 2025-05-05 | -9.60 |
| 2025-05-02 | -9.63 |
| 2025-05-01 | -9.57 |
| 2025-04-30 | -9.53 |
| 2025-04-29 | -9.51 |
| 2025-04-28 | -9.45 |
| 2025-04-25 | -9.24 |
| 2025-04-24 | -9.53 |
| 2025-04-23 | -9.24 |
| 2025-04-22 | -8.92 |
| 2025-04-21 | -8.60 |
| 2025-04-17 | -8.68 |
| 2025-04-16 | -8.44 |